Literature DB >> 912593

Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.

R J Winney, J M Bone, T J Anderson, J S Robson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 912593     DOI： 10.1007/bf02064047

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN： 0008-0594


× No keyword cloud information.
  9 in total

Review 1.  The kidney as an endocrine organ involved in the function of vitamin D.

Authors:  H F DeLuca
Journal:  Am J Med       Date:  1975-01       Impact factor: 4.965

2.  Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis.

Authors:  R Bouillon; R Verberckmoes; P D Moor
Journal:  Kidney Int       Date:  1975-06       Impact factor: 10.612

3.  1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.

Authors:  A E Fournier; P J Bordier; J Gueris; J Chanard; P Marie; C Ferriere; M Osario; J Bedrossian; H F de Luca
Journal:  Proc Eur Dial Transplant Assoc       Date:  1976

4.  1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure.

Authors:  T M Chalmers; J O Hunter; M W Davie; K F Szaz; B Pelc; E Kodicek
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

5.  Total body calcium and long-term calcium balance in chronic renal disease.

Authors:  J D Denney; D J Sherrard; W B Nelp; C H Chesnut; D J Baylink
Journal:  J Lab Clin Med       Date:  1973-08

6.  Control of secondary hyperparathyroidism during long-term hemodialysis.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; C D Arnaud
Journal:  Am J Med       Date:  1971-05       Impact factor: 4.965

7.  Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.

Authors:  A M Pierides; H A Ellis; W Simpson; J H Dewar; M K Ward; D N Kerr
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

8.  Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

Authors:  L Tougaard; E Sorensen; J Brochner-Mortensen; M S Christensen; P Rodbro; A W Sorensen
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

9.  Azotaemic renal osteodystrophy: a quantitative study on iliac bone.

Authors:  H A Ellis; K M Peart
Journal:  J Clin Pathol       Date:  1973-02       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.